期刊文献+

PET/CT在胰腺癌临床应用中的进展 被引量:10

Progress in the clinical application of in patients with pancreatic cancer
下载PDF
导出
摘要 胰腺癌是一类发病率高、早期诊断困难、治疗疗效不佳的消化系统恶性肿瘤.PET/CT作为现代医学成像重要组成内容之一,将PET的功能显像与CT的解剖成像有机融合,不仅能有效显示肿瘤的代谢、增生、乏氧和细胞凋亡状态,而且能精确显示肿瘤与其周围脏器组织的解剖结构.在胰腺癌患者的诊疗指导、肿瘤分期、疗效监控和预后评价等方面,PET/CT都具有重要的临床应用价值.本文将简要介绍PET/CT在胰腺癌临床应用中的进展情况. Pancreatic cancer, which has high morbidity, difficult diagnosis, and poor treatment results, is a type of malignant tumor in the digestive system. Positron emission tomographycomputed tomography, an important imaging modality in modern medicine, combines the functional imaging of PET and the anatomic imaging of CT to efficiently image tumor metabolism, proliferation, hypoxia and cell apoptosis. It can also precisely image the anatomic structure of tumors and their adjacent organs or tissues. Positron emission tomography-computed tomography was found to be particularly helpful for guiding diagnosis and therapy, the staging and grading of tumors, monitoring therapy and in evaluating the prognosis of patients with pancreatic cancer.
作者 王荣福
出处 《世界华人消化杂志》 CAS 北大核心 2007年第16期1830-1834,共5页 World Chinese Journal of Digestology
基金 国家重点基础研究发展计划基金-973计划 No.2006CB705705 北京大学985Ⅱ期基金资助 NO.985-2-056~~
关键词 PET/CT 胰腺癌 临床应用 进展 Positron emission tomography-computed tomography Pancreatic cancer Clinical application Progression
  • 相关文献

参考文献22

  • 1Papos M,Takacs T,Pavics L,Farkas G,Ambrus E,Szakall S Jr,Lonovics J,Csernay L,Tron L.The role of FDG-PET scan in the diagnosis of pancreatic carcinoma.Orv Hetif 2002:143:1283-1286
  • 2王荣福.肿瘤影像核医学进展[J].中国医学影像技术,2004,20(11):1792-1796. 被引量:16
  • 3王荣福.核医学[M].北京: 北京大学医学出版社,2004.1-15.
  • 4Michl P,Pauls S,Gress TM.Evidence-based diagnosis and staging of pancreatic cancer.Best Pract Res Clin Gastroenterol 2006;20:227-251
  • 5Valk PE,Bailey DL,Townsend DW,Maisey MN.Positron emission tomography,basic science and clinical practice.Springer Press,2003:588-594
  • 6Scott C L,Kudaba I,Stewart JM,Hicks RJ,Rischin D.The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin.Mol Imaging Biol 2005;7:236-243
  • 7Heinrich S,Goerres GW,Schafer M,Sagmeister M,Bauerfeind P,Pestalozzi BC,Hany TF,von Schulthess GK,Clavien PA.Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.Ann Surg 2005;242:235-243
  • 8Nishiyama Y,Yamamoto Y,Monden T,Sasakawa Y,Tsutsui K,Wakabayashi H,Ohkawa M.Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour.Nucl Med Commun 2005;26:895-901
  • 9Nishiyama Y,Yamamoto Y,Yokoe K,Monden T,Sasakawa Y,Tsutsui K,Satoh K,Ohkawa M.Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.Ann Nucl Med 2005;19:491-497
  • 10Takamori H,Kanemitsu K,Tsuji T,Kusano S,Chikamoto A,Okuma T,Iyama K.Metastatic gastric tumor secondary to pancreatic adenocarcinoma.J Gastroenterol 2005;40:209-212

二级参考文献3

共引文献17

同被引文献119

引证文献10

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部